Poland· PL-100377641
Sialanar
A glycopyrronium bromid product containing glycopyrronii bromidum, registered in Poland by Proveca Pharma Limited. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Glycopyrronium bromid is registered in 12 of 19 countries.
Countries holding a registration under ATC A03AB02 (glycopyrronium bromid), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Glycopyrronium bromid · ATC A03AB02
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Glycopyrronii bromidum
- Manufacturer
- Proveca Pharma Limited
- Country
- Poland (PL)
- ATC code
- A03AB02
- ATC class
- Glycopyrronium bromid
- Defined daily dose
- 3 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05060506950136
- gtin04150139469318
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Glycopyrronium bromid in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainSIALANAR 320 MICROGRAMOS/ML SOLUCION ORALProveca Pharma Limited
- NetherlandsSialanar 320 microgram/ml, drankProveca Pharma Limited
- ItalyGLICOPIRRONIO DOCDOC GENERICI S.R.L.
- IcelandEnurev BreezhalerNovartis Europharm Limited*
- SwitzerlandAxhidrox 2,2 mg/Hub, CremeGebro Pharma AG
- United StatesQbrexzaJourney Medical Corporation
- GermanyRybrilaColonis Pharma B.V.
- DenmarkEnurev BreezhalerNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Austria · Rybrila
- Germany · Rybrila
- Spain · Axhidrox
- Sweden · Glycopyrronium Cantabria
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/af68f88c-aa8c-4b2f-b00f-1f28aa2a47ae GET /v1/drugs/af68f88c-aa8c-4b2f-b00f-1f28aa2a47ae?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór doustny",
"source": "urpl",
"strength": "320 mcg/ml",
"packaging": "05060506950136 ¦ Rpz ¦ EU/1/16/1135/001 ¦ 117912\n1 butelka 250 ml ¦ 1 strzyk. 8 ml\n¦ UR/Z/4c/184/22 - 04150139469318 ¦ UR/Z/4c/083/23 - 04150139469318 ¦ UR/Z/4c/169/22 - 04150139469318\nRpz ¦ EU/1/16/1135/002 ¦ 148309\n1 butelka 60 ml ¦ 1 strzyk. 8 ml",
"substance": "Glycopyrronii bromidum 320 mcg/ml",
"common_name": "Glycopyrronii bromidum",
"pl_product_id": "100377641",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about glycopyrronium bromid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.